
Shreya Biswas
Articles
-
1 week ago |
today.westlaw.com | Sriparna Roy |Alan Barona |Manas Mishra |Shreya Biswas
(Reuters) -The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than two-year-long review process.
-
3 weeks ago |
today.westlaw.com | Puyaan Singh |Siddhi Mahatole |Shreya Biswas |Shailesh Kuber
(Reuters) -Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had called for an inspection of the facility that performs the testing of the drug.
-
1 month ago |
today.westlaw.com | Shreya Biswas |Seher Dareen
(Reuters) - Elliott Investment Management said on Tuesday it had filed a lawsuit in the Court of Chancery of the State of Delaware against refiner Phillips 66 and its Board of Directors, seeking an order that would require four board seats to be up...
-
1 month ago |
businessghana.com | Chandini Monnappa |Shreya Biswas
Saudi Aramco-backed industrial software company Cognite has opened an AI services centre in the southern Indian city of Bengaluru and said it is exploring potential contracts with top conglomerates in the country. The Norwegian company said it had signed up with a large industrial cement company and a major automotive company but declined to provide further details.
-
1 month ago |
gurutrade.com | Prakhar Srivastava |Shreya Biswas |Shilpi Majumdar
March 20 (Reuters) - Kraken said on Thursday it would buy retail futures trading platform NinjaTrader for $1.5 billion, in a deal that would allow one of the world's largest cryptocurrency exchanges to expand into multiple asset classes and grow its user base. The acquisition comes at a time when the crypto industry is optimistic about more relaxed regulation under U.S. President Donald Trump, who courted crypto donors during the election and promised to support the sector.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →